Research support expertise regarding the preclinical development of cap-dependent endonuclease inhibitors (cenis) with viruses that require biosafety level 4 (BSL-4) containment.

Active Purchase Order Awarded

Contract number
N0018926PB026
Awardee
Awarding agency
Obligated
$204,095

Award facts

Contract value 26% obligated
  • $204,095.04 Current, with exercised options
  • $794,077.08 Potential, with all options
Completion date 10% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Funding agency
Bureau of Medicine and Surgery Department of the Navy, Department of Defense
NAICS code
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
AN42 Health R&D Services; Health Care - Other; Applied Research
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Galveston, TX 77555, USA

Award details come from SAM.gov/FPDS.

Quick answers

Who was awarded contract N0018926PB026?

N0018926PB026 was awarded to University Of Texas Medical Branch At Galveston by Naval Supply Systems Command (Department of the Navy) on June 24, 2026.

How much is contract N0018926PB026 worth?

The government has obligated $204,095 on N0018926PB026. Its potential value, with all options, is $794,077.

Which agency awarded contract N0018926PB026?

Naval Supply Systems Command (Department of the Navy) awarded N0018926PB026, with funding from Bureau of Medicine and Surgery (Department of the Navy).

Was contract N0018926PB026 competed?

The extent of competition for N0018926PB026 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award